fbpx

molecules of the month

“compound 4d”

oral selective PI3K_ kinase inhibitor

<10 mg proj. human dose

from virtual screening and opt.

ACS Med. Chem. Lett., Nov. 19, 2020

Merck, Boston, CA

Structure of compound 4d
1 min read

“compound 4d” (Merck oral selective PI3K delta kinase inhibitor)


request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.


already a member? log in: